IBM and Novo Nordisk to create Artificial intelligence for insulin dosage accountancy

Tech Stocks Trend With advancement in technology, medical notion of “every disease is curable” is seeing further foresight. As per latest reports, Novo Nordisk is having a partnership with IBM Watson Health to come up with a virtual window to diabetes patients that could be able to dispense treatment advice like insulin dosage. IBM’s Watson was recognized in year 2011 for processing vast amounts of information to spot patterns and answer queries. That accomplishment further made International Business Machines Corporation to develop Watson Heath sector this year. Likewise, Novo Nordisk isn’t the first to apply the platform to health care. In year 2012, one of the earlier adopters was New York’s Memorial Sloan Kettering Cancer Center, which claimed to be working with IBM Watson in development of a tool that…


Link to Full Article: IBM and Novo Nordisk to create Artificial intelligence for insulin dosage accountancy